IMR Press / CEOG / Volume 41 / Issue 2 / DOI: 10.12891/ceog16302014

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Microwave endometrial ablation for hypermenorrhea treatment: a new era in Japan
Show Less
12 Department of Gynecology, Iseikai Hospital, Osaka (Japan)
Clin. Exp. Obstet. Gynecol. 2014, 41(2), 119–120;
Published: 10 April 2014

An estimated six million women in Japan suffer from excessive menstruation and the treatment of this disorder has been undergoing dramatic changes recently. In April 2012, microwave endometrial ablation (MEA) was approved for insurance coverage as a K863-3: a hysteroscopic endometrial ablation (17,810 points). Since the introduction of MEA to Shimane University Hospital in August 2007, authors (KN, KM) have performed the procedure in 96 patients with excessive menstruation. They have also evaluated its safety and its efficacy, not only by comparing it to the existing surgical treatment but by quantifying patients’ satisfaction levels and symptom improvement. The authors conclude that MEA is a safe, effective, a low-cost treatment, and they recommend that it be considered as a standard treatment for conservative therapy-resistant excessive menstruation.
Endometrial ablation
Insurance coverage
Back to top